BENZZ 100MG INJECTION contains Bendamustine, which belongs to the group of medicines called Anti-cancer agents. It is used to manage certain forms of cancer, such as chronic lymphocytic leukemia (cancer of the blood and bone marrow), Non-Hodgkin lymphomas (lymph cancer), and multiple myeloma (cancer of plasma cells).
BENZZ 100MG INJECTION can be used either alone or in combination with other anti-cancer agents to achieve better results. Therapy with BENZZ 100MG INJECTION is chosen only when the use of other first-line medicines is not suitable.
The use of BENZZ 100MG INJECTION may cause an abnormal decrease in white blood cells (WBC) and platelet count in the blood. To avoid this, your doctor will closely monitor your blood count periodically before and during management with BENZZ 100MG INJECTION.
Before receiving BENZZ 100MG INJECTION, inform your doctor if you have any liver, kidney, or heart problems. You must also inform your doctor if you have severe bone marrow depression, any infections, or severe changes in white blood cells and platelet count.
BENZZ 100MG INJECTION should not be used in pregnant or breastfeeding women, as it may cause serious harm to the growing fetus or nursing infant. Consult your doctor for advice.
The most common side effects of receiving BENZZ 100MG INJECTION are nausea, vomiting, hair loss, oral sores, diarrhea, constipation, fever, dehydration, headache, and tiredness. Contact your doctor if any of these side effects bother you.
No content available
